What is the recommended treatment for Lyme disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Lyme Disease

For early Lyme disease in adults, doxycycline 100 mg twice daily for 10-14 days is the preferred first-line treatment, with amoxicillin 500 mg three times daily for 14 days as an alternative for pregnant women and children under 8 years. 1, 2

First-Line Oral Regimens for Early Lyme Disease

Adults

  • Doxycycline 100 mg orally twice daily for 10-14 days (range 10-21 days) is the preferred agent because it also treats human granulocytic anaplasmosis (HGA), which can occur simultaneously with Lyme disease 1, 2
  • Amoxicillin 500 mg orally three times daily for 14-21 days is the alternative for pregnant/lactating women and when doxycycline is contraindicated 3, 2
  • Cefuroxime axetil 500 mg orally twice daily for 14-21 days is another effective option 2

Children

  • Children ≥8 years: Doxycycline 4 mg/kg per day in 2 divided doses (maximum 100 mg per dose) for 10-14 days 1, 2
  • Children <8 years: Amoxicillin 50 mg/kg per day in 3 divided doses (maximum 500 mg per dose) for 14 days 1, 2
  • Alternative for children <8 years: Cefuroxime axetil 30 mg/kg per day in 2 divided doses for 14 days 1

Important note: Recent evidence suggests doxycycline may be safe and effective in children under 8 years for courses ≤3 weeks, though amoxicillin remains preferred 4, 5. The 2018 American Academy of Pediatrics stated that up to 3 weeks of doxycycline is safe in children of all ages 5.

Duration Considerations

  • Doxycycline requires only 10 days due to its longer half-life 1, 2
  • β-lactam antibiotics (amoxicillin, cefuroxime) require a full 14-day course due to their shorter half-life 1
  • Extending treatment beyond 21 days is not supported by evidence and does not improve outcomes 2

Neurologic Lyme Disease

Isolated Facial Nerve Palsy (Seventh Cranial Nerve)

  • Oral antibiotics (same regimens as early Lyme disease) for 14-21 days if no clinical signs of meningitis and normal CSF or CSF examination deemed unnecessary 3
  • Lumbar puncture is indicated only if there is strong clinical suspicion of CNS involvement (severe/prolonged headache, nuchal rigidity) 3

Lyme Meningitis or CNS Involvement

  • Ceftriaxone 2 g IV once daily (or 50-75 mg/kg per day for children, maximum 2 g) for 14-28 days 3, 1, 6
  • Alternative: Cefotaxime 2 g IV every 8 hours (or 150-200 mg/kg per day divided into 3-4 doses for children, maximum 6 g per day) 3, 6
  • Alternative: Penicillin G 18-24 million units per day IV divided every 4 hours (or 200,000-400,000 units/kg per day for children) 3, 6
  • For penicillin-allergic patients: Doxycycline 200-400 mg/day orally or IV in 2 divided doses may be adequate 3

Lyme Carditis

  • Hospitalized patients with symptomatic carditis or second/third-degree heart block: Start with IV ceftriaxone (same dosing as meningitis), then switch to oral regimen to complete 14-21 days total 3
  • Outpatients with mild carditis: Oral regimens (same as early Lyme disease) for 14-21 days 3
  • Hospitalization and continuous monitoring are required for symptomatic patients (syncope, dyspnea, chest pain) or those with second/third-degree AV block, or first-degree block with PR interval ≥30 milliseconds 3

Lyme Arthritis

  • Initial treatment: Oral antibiotics (same regimens as early Lyme disease) for 28 days 3
  • If arthritis improves but not resolved: Consider a second 4-week course of oral antibiotics 3
  • If no response to oral therapy: IV ceftriaxone 2 g once daily for 14-28 days 3, 6
  • Antibiotic-refractory arthritis (persistent synovitis ≥2 months after IV ceftriaxone AND negative PCR for B. burgdorferi): Symptomatic treatment with NSAIDs, intra-articular corticosteroids, or DMARDs; consider arthroscopic synovectomy 3

Critical Administration Instructions

Doxycycline

  • Take with 8 ounces of fluid to reduce esophageal irritation 1, 7
  • Take with food to minimize gastrointestinal intolerance 1, 7
  • Avoid sun exposure due to photosensitivity risk 1, 7
  • Absorption is not significantly affected by food or milk, unlike other tetracyclines 7

Pregnancy and Lactation

  • Use amoxicillin or cefuroxime axetil; avoid doxycycline 3, 2
  • Treatment regimens are otherwise identical to non-pregnant patients 3

Common Pitfalls to Avoid

Ineffective Antibiotics (Never Use)

  • First-generation cephalosporins (e.g., cephalexin) are completely inactive against B. burgdorferi 1, 2, 6
  • Fluoroquinolones, carbapenems, vancomycin, metronidazole, tinidazole are ineffective 3, 6
  • Macrolides (azithromycin, clarithromycin, erythromycin) are significantly less effective and should only be used when patients cannot tolerate all first-line agents 1, 2, 6

Inappropriate Treatment Approaches

  • Long-term antibiotic therapy beyond recommended durations lacks supporting data and may cause harm 1, 6
  • Multiple repeated courses, combination therapy, or pulsed-dosing are not recommended 3, 6
  • Doses far in excess of standard regimens are not indicated 3

Post-Treatment Considerations

  • Serologic tests remain positive for months to years after successful treatment and should not be used to assess cure 6
  • Most patients respond promptly and completely to appropriate therapy 1
  • Less than 10% have persistent objective manifestations despite appropriate treatment 1
  • Persistent nonspecific symptoms without objective findings do not warrant additional antibiotics 6
  • Consider co-infections (Babesia, Anaplasma) if fever or characteristic laboratory abnormalities persist 6

budget:token_budget Tokens used this turn: 4523 Tokens remaining: 195477

References

Guideline

Treatment for Children with Borrelia burgdorferi (Lyme Disease)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Regimens for Early Lyme Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Doxycycline for the Treatment of Lyme Disease in Young Children.

The Pediatric infectious disease journal, 2023

Guideline

Treatment of Chronic Lyme Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.